SERVETTO, ALBERTO

SERVETTO, ALBERTO  

Dipartimento di Medicina clinica e Chirurgia  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.02 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer 1.1 Articolo in rivista 2022 Lee, Kyung-Min; Lin, Chang-Ching; Servetto, Alberto; Bae, Joonbeom; Kandagatla, Vishal; Ye, Dan; Kim, Gunmin; Sudhan, Dhivya R; Mendiratta, Saurabh; González Ericsson, Paula I; Balko, Justin M; Lee, Jeon; Barnes, Spencer; Malladi, Venkat S; Tabrizi, Siamak; Reddy, Sangeetha M; Yum, Seoyun; Chang, Ching-Wei; Hutchinson, Katherine E; Yost, Susan E; Yuan, Yuan; Chen, Zhijian J; Fu, Yang-Xin; Hanker, Ariella B; Arteaga, Carlos L
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges 1.1 Articolo in rivista 2022 Servetto, Alberto; Esposito, Daniela; Ferrara, Roberto; Signorelli, Diego; Belli, Stefania; Napolitano, Fabiana; Santaniello, Antonio; Ciciola, Paola; Formisano, Luigi; Bianco, Roberto
Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC 1.1 Articolo in rivista 2022 Salomone, Fabio; Di Costanzo, Fabrizio; Pecoraro, Giovanna; Viscardi, Giuseppe; Viggiano, Angela; Napolitano, Fabiana; Santaniello, Antonio; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer 1.1 Articolo in rivista 2022 Buonaiuto, Roberto; Napolitano, Fabiana; Parola, Sara; De Placido, Pietro; Forestieri, Valeria; Pecoraro, Giovanna; Servetto, Alberto; Formisano, Luigi; Formisano, Pietro; Giuliano, Mario; Arpino, Grazia; De Placido, Sabino; De Angelis, Carmine
FGFR1 Antibody Validation and Characterization of FGFR1 Protein Expression in ER+ Breast Cancer 1.1 Articolo in rivista 2022 Gonzalez-Ericsson, Paula I; Servetto, Alberto; Formisano, Luigi; Sánchez, Violeta; Mayer, Ingrid A; Arteaga, Carlos L; Sanders, Melinda E
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study 1.1 Articolo in rivista 2022 Servetto, Alberto; Santaniello, Antonio; Napolitano, Fabiana; Foschini, Francesca; Marciano, Roberta; Cascetta, Priscilla; Amato, Anna Rita; Augurio, Maria Rosaria; Maresca, Lucia; De Placido, Pietro; De Placido, Sabino; Formisano, Luigi; Bianco, Roberto
FGFR1 associates with gene promoters and regulates gene transcription: Implications for endocrine resistance in ER+/FGFR1-amplified breast cancer 8.02 Comunicazioni a Convegni o Seminari 2020 Servetto, A; Kollipara, R; Formisano, L; Lin, A; Lee, Km; Sudhan, Dr; Hanker, Ab; Chatterjee, S; Guerrero-Zotano, A; Gonzalez-Ericsson, ; Mendiratta, S; James, N; Kittler, R; Arteaga, Cl
Nuclear FGFR1 regulates gene transcription and promotes antiestrogen resistance in ERþ breast cancer 1.1 Articolo in rivista 2021 Servetto, A.; Kollipara, R.; Formisano, L.; Lin, C. -C.; Lee, K. -M.; Sudhan, D. R.; Gonzalez-Ericsson, P. I.; Chatterjee, S.; Guerrero-Zotano, A.; Mendiratta, S.; Akamatsu, H.; James, N.; Bianco, R.; Hanker, A. B.; Kittler, R.; Arteaga, C. L.
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity 1.1 Articolo in rivista 2021 Hanker, A. B.; Brown, B. P.; Meiler, J.; Marin, A.; Jayanthan, H. S.; Ye, D.; Lin, C. -C.; Akamatsu, H.; Lee, K. -M.; Chatterjee, S.; Sudhan, D. R.; Servetto, A.; Brewer, M. R.; Koch, J. P.; Sheehan, J. H.; He, J.; Lalani, A. S.; Arteaga, C. L.
FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors 1.1 Articolo in rivista 2021 Servetto, A.; Formisano, L.; Arteaga, C. L.
Use of folfirinox or nab-paclitaxel plus gemcitabine for the treatment of locally advanced pancreatic adenocarcinoma: A single institution observational study 1.1 Articolo in rivista 2021 Servetto, A.; Santaniello, A.; Napolitano, F.; Foschini, F.; Marciano, R.; Mozzillo, E.; Cascetta, P.; Amato, A. R.; Augurio, M. R.; Maresca, L.; De Placido, P.; De Placido, S.; Formisano, L.; Bianco, R.
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: a systematic review 1.1 Articolo in rivista 2022 Servetto, Alberto; Salomone, Fabio; Di Costanzo, Fabrizio; Iuliano, Rossella; Marandino, Laura; Napolitano, Fabiana; Santaniello, Antonio; De Placido, Pietro; De Placido, Sabino; Di Maio, Massimo; Formisano, Luigi; Bianco, Roberto
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer 1.1 Articolo in rivista 2021 Servetto, A.; Napolitano, F.; De Angelis, C.; De Placido, P.; Giuliano, M.; Arpino, G.; De Placido, S.; Bianco, R.; Formisano, L.
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors 1.1 Articolo in rivista 2018 Guerrero-Zotano, Angel; Stricker, Thomas; Formisano, Luigi; E Hutchinson, Katherine; Stover, Daniel G.; Lee, Kyung-min; J Schwarz, Luis; Giltnane, Jennifer M.; V Estrada, Monica; M Jansen, Valerie; Servetto, Alberto; Gavilá, Joaquín; Alejandro Pérez-Fidalgo, José; Lluch, Ana; Llombart-Cussac, Antonio; Amine Bayar, Mohamed; Michiels, Stefan; Andre, Fabrice; Arnedos, Monica; Guillem, Vicente; RUIZ-SIMON, Amparo
FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer. 1.1 Articolo in rivista 2019 Formisano, L; Drago, Jz; Juric, D; Niemierko, A; Servetto, A; Wander, Sa; Spring, Lm; Vidula, N; Younger, J; Peppercorn, J; Yuen, M; Malvarosa, G; Sgroi, D; Isakoff, Sj; Moy, B; Ellisen, Lw; Iafrate, Aj; Arteaga, Cl; Bardia, A
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. 1.1 Articolo in rivista 2019 Formisano, L; Lu, Y; Servetto, A; Hanker, Ab; Jansen, Vm; Bauer, Ja; Sudhan, Dr; Guerrero-Zotano, Al; Croessmann, S; Guo, Y; Ericsson, Pg; Lee, Km; Nixon, Mj; Schwarz, Lj; Sanders, Me; Dugger, Tc; Cruz, Mr; Behdad, A; Cristofanilli, M; Bardia, A; O'Shaughnessy, J; Nagy, Rj; Lanman, Rb; Solovieff, N; He, W; Miller, M; Su, F; Shyr, Y; Mayer, Ia; Balko, Jm; Arteaga, Cl.
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 1.1 Articolo in rivista 2017 Di Mauro, Concetta; Rosa, Roberta; D'Amato, Valentina; Ciciola, Paola; Servetto, Alberto; Marciano, Roberta; Orsini, Roberta Clara; Formisano, Luigi; De Falco, Sandro; Cicatiello, Valeria; Di Bonito, Maurizio; Cantile, Monica; Collina, Francesca; Chambery, Angela; Veneziani, BIANCA MARIA; De Placido, Sabino; Bianco, Roberto
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 1.1 Articolo in rivista 2020 Foschini, F.; Napolitano, F.; Servetto, A.; Marciano, R.; Mozzillo, E.; Carratu, A. C.; Santaniello, A.; De Placido, P.; Cascetta, P.; Butturini, G.; Frigerio, I.; Regi, P.; Silvestris, N.; Delcuratolo, S.; Vasile, E.; Vivaldi, C.; Bianco, C.; De Placido, S.; Formisano, L.; Bianco, R.
Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer 1.1 Articolo in rivista 2020 Lee, K. -M.; Guerrero-Zotano, A. L.; Servetto, A.; Sudhan, D. R.; Lin, C. -C.; Formisano, L.; Jansen, V. M.; Gonzalez-Ericsson, P.; Sanders, M. E.; Stricker, T. P.; Raj, G.; Dean, K. M.; Fiolka, R.; Cantley, L. C.; Hanker, A. B.; Arteaga, C. L.
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status 1.1 Articolo in rivista 2015 Formisano, Luigi; Valentina D'Amato, Null; Servetto, Alberto; Brillante, Simona; Raimondo, Lucia; Mauro, Concetta Di; Marciano, Roberta; Orsini, Roberta Clara; Cosconati, Sandro; Randazzo, Antonio; Parsons, Sarah; Montuori, Nunzia; Veneziani, BIANCA MARIA; Placido, Sabino De; Rosa, Roberta; Bianco, Roberto